REG - Abingdon Health PLC - Change of Nominated Adviser and Broker

Abingdon HealthAnnouncement

15/07/2024 07:00

For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20240715:nRSO2758Wa&default-theme=true

RNS Number : 2758W  Abingdon Health PLC  15 July 2024

 

 

 

Abingdon Health plc

 

("Abingdon Health" or "the Company")

 

Change of Nominated Adviser and Broker

 

The Company announces its Nominated Adviser and Broker has changed to Zeus
Capital Limited with immediate effect.

 

This change follows completion of the acquisition by Zeus Capital Limited of
the WH Ireland Capital Markets Division (from WH Ireland Limited), announced
earlier today.

 

For further information please contact:

 

 

Enquiries

 

 Abingdon Health plc                                 www.abingdonhealth.com/investors/ (http://www.abingdonhealth.com/investors/)
 Chris Yates, Chief Executive Officer
 Chris Hand, Non-Executive Chairman

 Zeus Capital (Sole Broker and Nominated Adviser)      Tel: +44 (0) 20 7220 1666
 Chris Fielding / Isaac Hooper (Corporate Finance)
 Fraser Marshall (Corporate Broking)

 

 

The person responsible for arranging the release of this announcement on
behalf of the Company is Chris Yates, Chief Executive Officer of the Company.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  APPFZGMNFZGGDZM